An Open-Label, Randomized, Phase 2 Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Non-Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma Patients.
Phase of Trial: Phase II
Latest Information Update: 13 Jan 2017
At a glance
- Drugs Bortezomib (Primary) ; Cyclophosphamide; Doxorubicin; Prednisone; Rituximab; Vincristine
- Indications Diffuse large B cell lymphoma
- Focus Therapeutic Use
- Acronyms PYRAMID
- Sponsors Takeda Oncology
- 08 Dec 2015 Results presented at the 57th Annual Meeting and Exposition of the American Society of Hematology
- 05 Nov 2015 Results from this trial will be presented at the 57th American Society of Hematology (ASH) Annual Meeting, according to a Takeda Pharmaceuticals media release.
- 09 Oct 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.